Cetrimide
Active ingredient · 2 therapeutic classes
Sold as CEANEL CONCENTRATE
- Drug class
- Quaternary Ammonium Compounds
- Availability
- See label
- Routes
- Topical
- Markets covered
- 2
- Products on record
- 19
Overview
Cetrimide is an active pharmaceutical ingredient in the Quaternary Ammonium Compounds group (D08AJ). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 17 | May 22, 2026 |
| CA Canada | Health Canada | 2 | March 22, 2025 |
GBUnited Kingdom· MHRA
17 products
Uses
Drapolene Derma is indicated for the relief of urinary dermatitis in adults, and as an adjunct to patient care hygiene for the prevention of urinary dermatitis. Drapolene Derma is indicated for the relief of nappy rash and for use as an adjunct to baby care hygiene for the prevention of nappy rash.
Drapolene Derma is indicated for the symptomatic relief of minor burns, limited sunburn and the effects of weather.
How to take
CACanada· Health Canada
2 products
2 products on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [2].
Sources & citations
- [1]MHRA (UK) · PL445430004 · revised May 22, 2026
- [2]Health Canada (DPD) · 00873195 · revised March 22, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.